Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 8/20 | 1.00 |
| ▸ | CNR2 | P34972 | 8/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.92 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.92 |
| ▸ | RGS12 | O14924 | 1/20 | 0.92 |
| ▸ | GMNN | O75496 | 1/20 | 0.92 |
| ▸ | LMNA | P02545 | 1/20 | 0.92 |
| ▸ | TP53 | P04637 | 1/20 | 0.92 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.92 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.92 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.92 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.92 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.92 |
| ▸ | THPO | P40225 | 1/20 | 0.92 |
| ▸ | BLM | P54132 | 1/20 | 0.92 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Win-552122 SCHEMBL29611661 | 1.00 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL3680086 | 1.00 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL29361053 | 1.00 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL29410177 | 1.00 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL29381882 | 1.00 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL10093015 | 1.00 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL31338445 | 0.98 | CNR1 (0.96) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL1517636 | 0.96 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL8071465 | 0.96 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 | |
| Win-552122 SCHEMBL29496357 | 0.96 | CNR1 (1.00) | CNR1CNR2ALDH1A1MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2858649-B1 | TREATMENT OF MOTOR AND MOVEMENT DISORDER SIDE EFFECTS ASSOCIATED WITH PARKINSON'S DISEASE TREATMENTS | PSYCHOGENICS INC (US) | 2019-10-23 | — | — | EP | claimed |
| US-20190142788-A1 | USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND RELATED CONNECTIVE TISSUE DISORDERS | INMED PHARMACEUTICALS INC. (CA) | 2019-05-16 | — | — | US | claimed |
| WO-2013025984-A2 | CANNABINOID RECEPTOR TREATMENTS | TEMPLE UNIVERSITY (US) | 2013-02-21 | — | — | WO | claimed |
| US-20120202891-A1 | Cannabinoid-Containing Compositions and Methods for Their Use | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2012-08-09 | — | — | US | claimed |
| EP-1785130-A2 | Hair and/or scalp treatment compositions | Unilever PLC (GB) | 2007-05-16 | — | — | EP | claimed |
| EP-1406576-A1 | HAIR AND/OR SCALP TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2004-04-14 | — | — | EP | claimed |
| US-20030049220-A1 | Hair and/or scalp treatment compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-03-13 | — | — | US | claimed |
| WO-2003007901-A1 | HAIR AND/OR SCALP TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2003-01-30 | — | — | WO | claimed |
| US-6503492-B2 | Antiperspirant or deodorant compositions | UNILEVER HOME & PERSONAL CARE USA, A DIVISION OF CONOPCO, INC. | 2003-01-07 | — | — | US | claimed |
| US-20020182159-A1 | ANTIPERSPIRANT OR DEODORANT COMPOSITIONS | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-12-05 | — | — | US | claimed |
| US-20260131008-A1 | HYALURONIC ACID BASED DRUG DELIVERY SYSTEMS | CELLA THERAPEUTICS LLC (US) | 2026-05-14 | — | — | US | disclosed |
| US-20250302771-A1 | TREATMENT OF OPIOID USE DISORDER, OPIOID WITHDRAWAL SYMPTOMS AND CHRONIC PAIN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250283122-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2025-09-11 | — | — | US | disclosed |
| US-20250170152-A1 | Cannabinoid Dosage Form | Emyria (AU) | 2025-05-29 | — | — | US | disclosed |
| US-20250064713-A1 | COSMETIC COMPOSITIONS | ELEBLEND LLC (US) | 2025-02-27 | — | — | US | disclosed |
| US-20030049220-A1 | Hair and/or scalp treatment compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-03-13 | — | — | US | disclosed |
| WO-2003007901-A1 | HAIR AND/OR SCALP TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2003-01-30 | — | — | WO | disclosed |
| US-6503492-B2 | Antiperspirant or deodorant compositions | UNILEVER HOME & PERSONAL CARE USA, A DIVISION OF CONOPCO, INC. | 2003-01-07 | — | — | US | disclosed |
| US-20020182159-A1 | ANTIPERSPIRANT OR DEODORANT COMPOSITIONS | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-12-05 | — | — | US | disclosed |
| US-20020111377-A1 | Transdermal delivery of cannabinoids | ALBANY COLLEGE OF PHARMACY | 2002-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064713-A1 | COSMETIC COMPOSITIONS | CUTA, SUCLG1, ASAH2 | CNR1 2691/4885CNR2 2053/4885ALDH1A1 874/4885 |
| US-20260131008-A1 | HYALURONIC ACID BASED DRUG DELIVERY SYSTEMS | SLC26A6, SLC26A3, SLC9A2 | CNR1 1606/4885CNR2 1399/4885ALDH1A1 979/4885 |
| US-20120202891-A1 | Cannabinoid-Containing Compositions and Methods for Their Use | CNR2, CNR1, FAAH | CNR1 2/4885CNR2 1/4885ALDH1A1 3754/4885 |
| US-20190142788-A1 | USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND RELATED CONNECTIVE TISSUE DISORDERS | KRT18, DSP, DSC1 | CNR1 60/4885CNR2 28/4885ALDH1A1 4687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.